Filings · News reference
Nutex Health Reports Data Exfiltration And Faces Class-Action Lawsuit Following Cyberattack, Filed August 27, 2026 In U.S. District Court, Houston; Complaint Seeks Damages, Injunctive Relief, Credit Monitoring, Identity Theft Insurance, Attorneys' Fees; Says Unable To Predict Outcome Of Litigation Or Estimate Incident Impact At This Stage
As disclosed in Item 8.01 of a Current Report on Form 8-K filed with the Securities and Exchange Commission on August 24, 2026 (the "Prior 8-K"), Nutex Health Inc. (the "Company") became aware of
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Freedom Capital Markets Maintains Buy on Nutex Health, Raises Price Target to $306
Freedom Capital Markets analyst Gene Mannheimer maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $280 to $306.
Reported Earlier, Nutex Health Approved For Dual Listing On Nasdaq Texas, Trading Set To Commence September 23, 2026
Nutex Health Q2 2026 Earnings Call: Complete Transcript
Nutex Health (NASDAQ:NUTX) released second-quarter financial results and hosted an earnings call on Friday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time access to